Key result
Catecholamine-induced coronary vasodilatation is primarily driven by increased myocardial oxygen consumption rather than direct beta-adrenergic receptor stimulation, which plays a minor physiological role.
Why the study?
Do coronary blood vessels contain an intrinsic adrenergic mechanism for vasodilatation of physiological significance?
Do coronary blood vessels contain an intrinsic adrenergic mechanism for vasodilatation of physiological significance?
Adrenergic beta-receptors exist in coronary vessels and mediate vasodilatation, but this effect is physiologically minor compared to vasodilatation driven by myocardial oxygen consumption.
Authors
No takes yet. Share an insight, caveat, or question.
Metabolic dominance over direct beta-effects in animal coronary vessels; leaves open human relevance and should not yet change practice.
Imai et al. (1975) studied Healthy (animal model). Catecholamines (epinephrine, norepinephrine, isoproterenol, salbutamol) vs. Baseline and adrenergic blockade (practolol, phentolamine) was evaluated on Relationship between coronary blood flow and myocardial oxygen consumption. Catecholamine-induced coronary vasodilatation is primarily driven by increased myocardial oxygen consumption rather than direct beta-adrenergic receptor stimulation, which plays a minor physiological role.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: